Stueland Katherine bought WGS
March 3, 2026 · Form 4 insider transaction
Stueland Katherine bought 47,684 shares of GeneDx Holdings Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
47,684
Price
$0.00
Total value
N/A
InsiderStueland Katherine
RoleOfficer, Director
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after64,142
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported transaction represents the certification of achievement of a performance-based restricted stock unit award granted to the Reporting Person by the Issuer's compensation committee on March 15, 2025 (the "2025 PRSU Award"). Vesting of the 2025 PRSU Award is based on achievement of corporate performance metrics tied to revenue and adjusted net income, and subject to the Reporting Person's continued service through the certification date of achievement thereof.